Sensi SL

Department of Neurosciences, Imaging and Clinical Sciences, University "G. D'Annunzio", Chieti, Italy.

13 papers · 1 preprint · ORCID

ArticlePsychedelics

Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care.

Pettorruso M, d'Andrea G, Inserra A +12

Europe PMC2026
ArticleKetamine

Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.

d'Andrea G, Chiappini S, Ciavoni L +13

Europe PMC2025
ArticleKetamine

Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.

d'Andrea G, Cavallotto C, Pettorruso M +25

Europe PMC2025
ArticleKetamine

Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study.

d'Andrea G, Miuli A, Pettorruso M +12

Europe PMC2024
ArticleKetamine

The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.

d'Andrea G, Pettorruso M, Di Lorenzo G +16

Europe PMC2024
ArticlePsychedelics

The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics.

Onofrj M, Russo M, Delli Pizzi S +4

Europe PMC2023
ArticleLSD

LSD-induced changes in the functional connectivity of distinct thalamic nuclei.

Delli Pizzi S, Chiacchiaretta P, Sestieri C +10

Europe PMC2023
ArticleKetamine

Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).

Pettorruso M, Guidotti R, d'Andrea G +25

Europe PMC2023
ArticleKetamine

Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group.

d'Andrea G, Chiappini S, McIntyre RS +12

Europe PMC2023
ArticlePsilocybin

In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.

Luppi AI, Hansen JY, Adapa R +23

Europe PMC2023
ArticleLSD

Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression.

Delli Pizzi S, Chiacchiaretta P, Sestieri C +8

Europe PMC2023
ArticleKetamine

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.

Martinotti G, Dell'Osso B, Di Lorenzo G +23

Europe PMC2023
PreprintPsilocybin

Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape

Luppi AI, Hansen JY, Adapa R +24

Europe PMC2022
ArticleKetamine

Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature.

Martinotti G, Chiappini S, Pettorruso M +8

Europe PMC2021